Current nephrology practice starts by patient-doctor interactions and can lead to investigations. Genetic testing has had a limited role in these investigations. In the future era of precision medicine, adding genomic sequencing early in the management paradigm could modify treatment plans. Genomic approaches followed by physician planning for targeted treatment of renal disease and transplant are precision medicine tools that can lead to better prognosis and medical outcomes.